A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine

Optimal clinical outcomes in cancer treatments could be achieved through the development of reliable, precise ex vivo tumor models that function as drug screening platforms for patient-targeted therapies. Microfluidic tumor-on-chip technology is emerging as a preferred tool since it enables the comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Eliana, Friedman, Roy, Goldstein, Yoel, Friedman, Nethanel, Beharier, Ofer, Demma, Jonathan Abraham, Zamir, Gideon, Hubert, Ayala, Benny, Ofra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643569/
https://www.ncbi.nlm.nih.gov/pubmed/37957280
http://dx.doi.org/10.1038/s42003-023-05531-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643569/
https://www.ncbi.nlm.nih.gov/pubmed/37957280
http://dx.doi.org/10.1038/s42003-023-05531-5

Ejemplares similares